Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of ARS 29.85 trillion. The enterprise value is 20.22 trillion.

Market Cap	29.85T
Enterprise Value	20.22T

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.30%
Shares Change (QoQ)	+0.51%
Owned by Insiders (%)	6.64%
Owned by Institutions (%)	80.82%
Float	368.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.58
PB Ratio	2.38
P/TBV Ratio	2.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.94
EV / Sales	7.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.74

Financial Position

The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.15.

Current Ratio	3.29
Quick Ratio	3.06
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	-0.63
Interest Coverage	-307.40

Financial Efficiency

Return on equity (ROE) is -28.87% and return on invested capital (ROIC) is -63.28%.

Return on Equity (ROE)	-28.87%
Return on Assets (ROA)	-14.51%
Return on Invested Capital (ROIC)	-63.28%
Return on Capital Employed (ROCE)	-29.70%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	600.32M
Profits Per Employee	-871.46M
Employee Count	4,700
Asset Turnover	0.15
Inventory Turnover	29.63

Taxes

In the past 12 months, Moderna has paid 78.38 billion in taxes.

Income Tax	78.38B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +85.13% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+85.13%
50-Day Moving Average	3,197.37
200-Day Moving Average	2,243.52
Relative Strength Index (RSI)	63.97
Average Volume (20 Days)	85,218

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.12

Income Statement

In the last 12 months, Moderna had revenue of ARS 2.82 trillion and -4,095.85 billion in losses. Loss per share was -10,529.18.

Revenue	2.82T
Gross Profit	-2,984.08B
Operating Income	-4,461.60B
Pretax Income	-4,017.48B
Net Income	-4,095.85B
EBITDA	-4,149.55B
EBIT	-4,461.60B
Loss Per Share	-10,529.18

Balance Sheet

The company has 8.42 trillion in cash and 1.89 trillion in debt, with a net cash position of 9.91 trillion.

Cash & Cash Equivalents	8.42T
Total Debt	1.89T
Net Cash	9.91T
Net Cash Per Share	n/a
Equity (Book Value)	12.55T
Book Value Per Share	31,864.49
Working Capital	6.61T

Cash Flow

In the last 12 months, operating cash flow was -2,718.47 billion and capital expenditures -278.67 billion, giving a free cash flow of -2,997.14 billion.

Operating Cash Flow	-2,718.47B
Capital Expenditures	-278.67B
Free Cash Flow	-2,997.14B
FCF Per Share	n/a

Margins

Gross margin is -105.76%, with operating and profit margins of -158.13% and -145.16%.

Gross Margin	-105.76%
Operating Margin	-158.13%
Pretax Margin	-142.39%
Profit Margin	-145.16%
EBITDA Margin	-147.07%
EBIT Margin	-158.13%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.30%
Shareholder Yield	-1.30%
Earnings Yield	-13.72%
FCF Yield	-10.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 2.44 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.44
Piotroski F-Score	1